Cellular Plasticity and Disease news

<p>Image: BIST</p>
27 Jun 2018

BIST Director General says modernising research facilities and providing training to boost the social impact of science are the top priorities of the Barcelona Institute of Science and Technology

Barry C. Barish presents theory and technology behind measuring gravitational waves developed at LIGO, for which he won the 2017 Nobel Prize in Physics 

<p>Manuel Serrano, head of the Cellular Plasticity and Disease laboratory at IRB Barcelona</p>
25 Jun 2018

TV3’s "30 Minuts" has devoted a programme to whether it will be possible to extend life beyond the current limits, by slowing down or stopping aging as if it were a disease. For this documentary, they interviewed Manuel Serrano, ICREA researcher at IRB Barcelona, who comments on the process of senescence and zombie cells: "For example, if you smoke, the aging process accelerates and these zombie cells accumulate".

Link to TV3

<p>Image: BIST</p>
20 Jun 2018

Barry Barish, 2017 Nobel laureate in Physics, will speak about the ‘new science’ arising from the proof found in 1915 for the gravitational waves Einstein predicted.

The scientific re-evolution based on the new power paradigm, the latest advances in biosensors and in vitro production of specialised cells and human organs are the topics of the three debate panels.

<p>Image: El País</p>
15 Jun 2018

The newspaper El País has published an article about the implications of applying the CRISPR-Cas9 technique in human cells that could facilitate the appearance of tumours, according to two articles published in the journal Nature Medicine. The journalist interviewed Manuel Serrano, head of the Cellular Plasticity and Disease Lab at IRB Barcelona, who does not consider that these results are completely pessimistic because "Once a genetic defect has been corrected, it can be verified if these cells maintain p53, so we will have to add another quality test to use the cells that maintain it and not the others ".

Link to...

5 Jun 2018

This weekend the Ciutadella Park will be hosting this event, which will showcase 230 scientific activities aimed at the general public.

IRB Barcelona will be participating through two workshops and a micro-talk, related to microscopy, cancer research and ageing.

<p>Manuel Serrano, head of the Cellular Plasticity and Disease laboratory at IRB Barcelona</p>
14 May 2018

El Economista, Cuatro, Geriatricarea, among other media, have published articles about the award received by Manuel Serrano, head of the Cellular Plasticity and Disease Lab at IRB Barcelona, for his work "Tissue damage and senescence provide critical signals for cell reprogramming in vivo".

Link to El Economista

Link to Cuatro

Link to...

<p>Manuel Serrano at the ceremony held at Caixaforum in Madrid</p>
8 May 2018

Sergi Ferrer-Salat, president of the Board of Trustees of the Ferrer Research Foundation, highlighted that the work done by IRB Barcelona scientist, Manuel Serrano, is helping to further our understanding of the relation between ageing and cancer and identify approaches to manipulate this relation to our advantage.

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory</p>
4 Apr 2018

La Opinión A Coruña, La Nueva España, Faro de Vigo, among other media, have published an interview with Manuel Serrano, head of the Cellular Plasticity and Disease Lab at IRB Barcelona, about his career and the work being done at the centre.

Link to La Opinión A Coruña

Link to Faro de vigo

 

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory</p>
5 Feb 2018

The newspaper ABC has published an article about the group of scientists and medicsl doctors that is facing cancer. In the article, they mention Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona, who affirms that the great challenge of regenerative medicine is to know how tissues react to damage and how they self-repair.

Link to: ABC.es

<p>Manuel Serrano Lab</p>
19 Jan 2018

It is a factor that has been conserved through evolution, from plants to mammals

RPAP1 regulates the activity of RNA polymerase II by means of its interaction with gene transactivators